These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 4770231)

  • 1. [Documentation of the biologic availability of oral pharmaceutic forms].
    Tommasini R
    Boll Chim Farm; 1973 Aug; 112(8):494-7. PubMed ID: 4770231
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biologic availability as a function of the pharmaceutic form].
    Cardini C; Mazzaracchio F; Quercia V
    Boll Chim Farm; 1974 Aug; 113(8):455-7. PubMed ID: 4433431
    [No Abstract]   [Full Text] [Related]  

  • 3. The physiologic availability of solid dosage forms of phenylbutazone. I. In vivo physiologic availability and pharmacologic considerations.
    Van Petten GR; Feng H; Withey RJ; Lettau HF
    J Clin Pharmacol New Drugs; 1971; 11(3):177-86. PubMed ID: 5211351
    [No Abstract]   [Full Text] [Related]  

  • 4. [In vitro and in vivo studies on a new anti-inflammatory agent for the production of an oral pharmaceutic form with increased biological availability].
    Simioni L; Buttinoni A; Tamassia V
    Boll Chim Farm; 1974 Apr; 113(4):232-40. PubMed ID: 4848925
    [No Abstract]   [Full Text] [Related]  

  • 5. The physiologic availability of solid dosage forms of phenylbutazone. II. Correlation of in vivo physiologic availability and in vitro dissolution parameters.
    Withey RJ; Feng H; Cook D; Van Petten GR; Lettau HF
    J Clin Pharmacol New Drugs; 1971; 11(3):187-96. PubMed ID: 5211352
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug formulation and biologic availability.
    Poole JW
    Semin Drug Treat; 1971 Sep; 1(2):148-76. PubMed ID: 5153883
    [No Abstract]   [Full Text] [Related]  

  • 7. [In vitro evaluation of biologic availability of solid peroral dosages].
    Ceschel GC; Duncan S; Dall'Olio G; Lupo C; Giani C
    Boll Chim Farm; 1973 Oct; 112(10):645-64. PubMed ID: 4782260
    [No Abstract]   [Full Text] [Related]  

  • 8. [Biologic availability of various formulas of nitrofurantoin in tablets].
    Frigerio G; Venier A
    Boll Chim Farm; 1973; 112(6):416-21. PubMed ID: 4767643
    [No Abstract]   [Full Text] [Related]  

  • 9. [Formulation and operative factors in relation to the physiological availabiltiy of drugs in oral preparations].
    Guadagnini G; Neri G; Rugginenti GC; Vannini E
    Boll Chim Farm; 1973 Nov; 112(11):719-33. PubMed ID: 4786711
    [No Abstract]   [Full Text] [Related]  

  • 10. [Editorial: Biologic availability--aspects related to general practice].
    Schmidt R
    Schweiz Rundsch Med Prax; 1974 Jun; 63(23):697-8. PubMed ID: 4838647
    [No Abstract]   [Full Text] [Related]  

  • 11. Non-equivalence of digoxin tablets.
    Reissell P; Manninen V; Ojala K; Karjalainen J
    Ann Clin Res; 1974; 6(0):suppl 11:4-8. PubMed ID: 4853359
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative biopharmaceutical study of tegalide].
    Lopatina NB; Lebedeva MN
    Med Parazitol (Mosk); 2000; (1):27-9. PubMed ID: 10808715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biopharmaceutical aspects of oral dosage forms].
    Ross G; Hiller D
    Pharm Unserer Zeit; 1974 Sep; 3(5):153-61. PubMed ID: 4408669
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effectivness prolongation of drugs with special consideration for peroral depot drug forms].
    Hänselmann B; Voigt R
    Pharmazie; 1971 Feb; 26(2):57-77. PubMed ID: 4930108
    [No Abstract]   [Full Text] [Related]  

  • 15. Some dissolution aspects of ferrous sulfate tablets.
    Blezek CE; Lach JL; Guillory JK
    Am J Hosp Pharm; 1970 Jul; 27(7):533-9. PubMed ID: 5431051
    [No Abstract]   [Full Text] [Related]  

  • 16. [Development of an oral nitroglycerin proxyphyllin retard compound].
    Ritschel WA; Clotten R
    Arzneimittelforschung; 1970 Sep; 20(9):1180-7. PubMed ID: 4992053
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative study of the physiological availability of 2 oral formulations of diazepam].
    Dugal R; Caillé G; Brodeur J; Cooper S; Besner JG
    Union Med Can; 1973 Aug; 103(8):1744-8. PubMed ID: 4792864
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparative gaschromatographic study on absorption of diazepam tablets in man. A gaschromatographic study with Ni63-detector by determining diazepam concentrations in plasma.
    Kangas L; Pekkarinen A; Sourander C; Raijola E
    Ann Clin Res; 1974; 6(0):suppl 11:12-20. PubMed ID: 4855460
    [No Abstract]   [Full Text] [Related]  

  • 19. A disintegration test for evaluation of drug availability from tablets and capsules.
    Sandell E; Eriksson K; Mellström G
    Acta Pharm Suec; 1970 Nov; 7(5):559-66. PubMed ID: 5275191
    [No Abstract]   [Full Text] [Related]  

  • 20. [Study of the stability and biologic availability of a sulfomucopolysaccharide administered orally].
    Zannotti A; Bufalino L; Landi A; Mantovani V; Bianchini P
    Farmaco Prat; 1974 May; 29(5):264-71. PubMed ID: 4276917
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.